ELGX

Endologix (ELGX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ELGX
DataOraFonteTitoloSimboloCompagnia
05/10/202012:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ELGXEndologix Inc
01/10/202021:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELGXEndologix Inc
01/10/202019:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ELGXEndologix Inc
01/10/202018:04Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ELGXEndologix Inc
01/10/202017:51Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELGXEndologix Inc
01/10/202017:22Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ELGXEndologix Inc
17/09/202022:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELGXEndologix Inc
14/08/202023:54Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:ELGXEndologix Inc
10/08/202012:17Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:ELGXEndologix Inc
10/07/202022:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ELGXEndologix Inc
06/07/202004:35Business Wire Endologix Enters into an Agreement with Deerfield Partners to Take the Company PrivateNASDAQ:ELGXEndologix Inc
25/06/202014:00PR Newswire (US)Sight Sciences Strengthens Its Leadership Team with Chief Operating Officer and General Counsel HiresNASDAQ:ELGXEndologix Inc
18/06/202022:30Business WireEndologix Announces Departure of CFO and Appointment of Interim CFONASDAQ:ELGXEndologix Inc
15/06/202022:01Business WireEndologix Issues Correction Notice for Ovation iX Abdominal Stent Graft SystemNASDAQ:ELGXEndologix Inc
28/05/202022:10Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:ELGXEndologix Inc
27/05/202015:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ELGXEndologix Inc
11/05/202022:03Business WireEndologix Announces Completion of Enrollment in the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix EndoVascular Ane...NASDAQ:ELGXEndologix Inc
11/05/202022:01Business WireEndologix Reports First Quarter 2020 Financial ResultsNASDAQ:ELGXEndologix Inc
01/05/202022:01Business WireEndologix, Inc. to Announce First Quarter 2020 Financial Results on May 11, 2020NASDAQ:ELGXEndologix Inc
27/04/202022:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ELGXEndologix Inc
14/04/202022:01Business WireEndologix Appoints Tim A. Benner as Chief Commercial OfficerNASDAQ:ELGXEndologix Inc
06/04/202014:00Business WireEndologix Announces Preliminary Financial Results for First Quarter 2020NASDAQ:ELGXEndologix Inc
30/03/202014:00Business WireEndologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ELGXEndologix Inc
17/03/202023:30Business WireEndologix Adds Jane E. Kiernan to its Board of DirectorsNASDAQ:ELGXEndologix Inc
16/03/202014:00Business WireEndologix Receives FDA Approval for Alto Abdominal Stent Graft SystemNASDAQ:ELGXEndologix Inc
11/03/202022:15Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ELGXEndologix Inc
24/02/202014:55Business WireEndologix Announces Debt Restructuring Addressing 2020 MaturitiesNASDAQ:ELGXEndologix Inc
19/02/202022:01Business WireEndologix Reports Fourth Quarter and Fiscal Year 2019 Financial ResultsNASDAQ:ELGXEndologix Inc
18/02/202014:00Business WireEndologix, Inc. to Present at the SVB Leerink Global Healthcare ConferenceNASDAQ:ELGXEndologix Inc
14/02/202022:57Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ELGXEndologix Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ELGX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network